"Innovent and Roche link on lung cancer therapy development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

Innovent, which has operations in Suzhou and San Francisco, said this morning that its placebo-controlled DREAMs-1 trial of mazdutide in Chinese adults with type 2 diabetes inadequately controlled ...

Speaking at the Tata Technologies InnoVent Demo Day felicitation ceremony, Mr. Warren Harris, CEO & MD of Tata Technologies stated, "Tata Technologies vision of Engineering a better world embodies ...

Developed leveraging Innovent's proprietary novel topoisomerase 1 inhibitor (TOPO1i) platform, IBI3009 is one of the leading and potentially best-in-class DLL3-targeting ADCs. IBI3009 has shown ...

SAN FRANCISCO and SUZHOU, China, Jan. 5, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...